Premier clients ZoomRx already partners with 19 of the top 20 global pharma firms and serves over 100 firms, indicating a strong track record and an opportunity to upsell existing top-tier clients with new AI-enabled offerings like Signal-IQ and Sagan Agents.

AI plus human With an AI-first approach that amplifies human expertise, there is a clear cross-sell path to pharma and biotech companies seeking faster, deeper insights without sacrificing rigor—target clients looking to accelerate market strategy development.

Real-time intelligence Recent launches such as Signal-IQ for competitive field intelligence and TV Tracking positioning ZoomRx to address competitive intelligence, market access, and media optimization needs in life sciences—sell these capabilities to teams focused on field readiness and ROI.

Scale and reach A global consultant network of over 450 life sciences professionals and 60k+ HCPs in proprietary panels enables scalable, multi-therapy and global market deployment—target multinational brands seeking consistent, rapid insights across regions.

Strong growth signals Revenue range of 100M to 250M and a 100% client renewal rate signal stability and potential for expansion into adjacent service lines such as AI-enabled launch research, therapy-area deep dives, and strategic advisory for late-stage development.